KIRKLAND, Wash.--Rosetta Inpharmatics last month signed an alliance with Agilent Technologies, a subsidiary of Hewlett-Packard, to develop its new gene expression bio-informatics tool called Resolver Expression Data Analysis System. The Chemical Analysis Group of Agilent, which made an equity investment in Rosetta, will distribute the system. The two companies said they expect to jointly invest $75 million over a three-year period. Resolver combines software, hardware, and database architecture to enable storage, retrieval, and high-level analysis of expression data.
Rosetta also recently announced the launch of a new website at http://www.rii.com.